Finally, a recent meta-analysis by Shou et al. demonstrated a lack of prognostic impact of SETBP1 mutations in CNL, although these mutations were significantly associated with poor prognosis in MDS and CMML136. The gene discussed is SETBP1; the disease is myelodysplastic syndrome.